Charles Watts's most recent trade in Biodesix Inc was a trade of 46,686 Common Stock done . Disclosure was reported to the exchange on March 31, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biodesix Inc | Charles Watts | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 46,686 | 421,705 | - | - | Common Stock | |
| Biodesix Inc | Charles Watts | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 46,686 | 0 | - | - | Restricted Stock Units | |
| Biodesix Inc | Charles Watts | Director | 16 Jul 2024 | 26,368 | 0 | - | - | Restricted Stock Units | ||
| Biodesix Inc | Charles Watts | Director | 16 Jul 2024 | 26,368 | 375,019 | - | - | Common Stock | ||
| Biodesix Inc | Charles Watts | Director | 21 May 2024 | 46,686 | 46,686 | - | - | Restricted Stock Units | ||
| Biodesix Inc | Charles Watts | Director | 21 May 2024 | 37,050 | 37,050 | - | - | Stock Options (Right to Buy) | ||
| Biodesix Inc | Charles Watts | Director | 01 Apr 2024 | 134,262 | 0 | - | - | Restricted Stock Units | ||
| Biodesix Inc | Charles Watts | Director | 01 Apr 2024 | 134,262 | 348,651 | - | - | Common Stock | ||
| Biodesix Inc | Charles Watts | Director | 01 Jan 2024 | 105,389 | 134,262 | - | - | Restricted Stock Units | ||
| Biodesix Inc | Charles Watts | Director | 03 Aug 2023 | 12,345 | 214,389 | - | 1.6 | 19,999 | Common Stock | |
| Biodesix Inc | Charles Watts | Director | 23 May 2023 | 28,873 | 28,873 | - | - | Restricted Stock Units | ||
| Accelerate Diagnostics Inc | Charles Watts | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2023 | 69,619 | 69,619 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | Charles Watts | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2023 | 69,619 | 0 | - | - | Employee Restricted Stock Units | |
| Biodesix Inc | Charles Watts | Director | 31 Mar 2023 | 150,711 | 0 | - | - | Restricted Stock Units | ||
| Biodesix Inc | Charles Watts | Director | 31 Mar 2023 | 150,711 | 202,044 | - | - | Common Stock | ||
| Biodesix Inc | Charles Watts | Director | 03 Jan 2023 | 4,878 | 150,711 | - | - | Restricted Stock Units | ||
| Biodesix Inc | Charles Watts | Director | 01 Jan 2023 | 62,500 | 145,833 | - | - | Restricted Stock Units | ||
| Biodesix Inc | Charles Watts | Director | 21 Nov 2022 | 43,478 | 51,333 | - | 1.2 | 50,000 | Common Stock | |
| Accelerate Diagnostics Inc | Charles Watts | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 75,949 | 75,949 | - | - | Employee Restricted Stock Units | |
| Biodesix Inc | Charles Watts | Director | 24 May 2022 | 83,333 | 83,333 | - | - | Restricted Stock Units | ||
| Biodesix Inc | Charles Watts | Director | 20 Dec 2021 | 5,855 | 7,855 | - | 4.3 | 25,132 | Common Stock | |
| Biodesix Inc | Charles Watts | Director | 29 Jun 2021 | 34,385 | 34,385 | - | - | Stock Options (Right to buy) | ||
| Accelerate Diagnostics Inc | Charles Watts | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 35,168 | 35,168 | - | - | Stock Option (right to buy) | |
| Biodesix Inc | Charles Watts | Director | 30 Oct 2020 | 2,000 | 2,000 | - | 18 | 36,000 | Common Stock |